The therapeutic role of very low-density lipoprotein receptor gene in hyperlipidemia in type 2 diabetic rats

Human Gene Therapy

Volumn 22, Issue 3, 2011, Pages 302-312

  Yuan, Gang ^a   Liu, Yongjian ^a   Sun, Tingting ^a   Xu, Yongping ^a   Zhang, Jianhuan ^a   Yang, Yan ^a   Zhang, Muxun ^a   Cianflone, Katherine ^b   Wang, Dao Wen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CHOLESTEROL; GLUCOSE; INSULIN; LIPOPROTEIN LIPASE; MESSENGER RNA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; CELL STRAIN 3T3; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOCYTES; ANIMALS; AORTA; BLOOD GLUCOSE; BODY WEIGHT; CELL DIFFERENTIATION; CELLS, CULTURED; CHOLESTEROL; DEPENDOVIRUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HUMANS; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; RATS; RATS, WISTAR; RECEPTORS, LDL; TRIGLYCERIDES;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 79952661472     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.038     Document Type: Article

References (44)

1. American Diabetes Association. (1989). Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diabetes Care 12, 573-579.
2. Bollag, D.M., and Edelstein, S.J. (1991). Preparation for protein isolation. In Protein Methods. D.M. Bollag, M.D. Rozycki, and S.J. Edelstein, eds. (Wiley-Liss, New York) pp. 1-43.
3. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Chen, S.J., Rader, D.J., Tazelaar, J., Kawashiri, M., Gao, G., and Wilson, J.M. (2000). Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipopro-tein receptor. Mol. Ther. 2, 256-261.
5. Douillet, C.D., Velarde, V., Christopher, J.T., Mayfield, R.K., Trojanowska, M.E., and Jaffa, A.A. (2000). Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: Role of TGF-b and MAPK. Am. J. Physiol. Heart Circ. Physiol. 279, 2829-2837.
6. Frykman, P.K., Brown, M.S., Yamamoto, T., Goldstein, J.L., and Herz, J. (1995). Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl. Acad. Sci. U.S.A. 92, 8453-8457.
7. Gafvels, M.E., Caird, M., Britt, D., Jackson, C.L., Patterson, D., and Strauss, J.F., III. (1993). Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23. Somat. Cell Mol. Genet. 19, 557-569. (Pubitemid 24116672)
8. Gafvels, M.E., Paavola, L.G., Boyd, C.O., Nolan, P.M., Witt-maack, F., Chawla, A., Lazar, M.A., Bucan, M., Angelin, B.O., and Strauss, J.F., III. (1994). Cloning of a complementary deoxyribonucleic acid encoding the murine homolog of the very low density lipoprotein/apolipoprotein-E receptor: Expression pattern and assignment of the gene to mouse chromosome 19. Endocrinology 135, 387-394.
9. Ginsberg, H.N. (1996). Diabetic dyslipidemia: Basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes 45, S27-S30.
10. Ginsberg, H.N., Zhang, Y.L., and Hernandez-Ono, A. (2005). Regulation of plasma triglycerides in insulin resistance and diabetes. Arch. Med. Res. 36, 232-240. (Pubitemid 40755136)
11. Goudriaan, J.R., Espirito Santo, S.M., Voshol, P.J., Teusink, B., van Dijk, K.W., van Vlijmen, B.J., Romijn, J.A., Havekes, L.M., and Rensen, P.C. (2004). The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45, 1475-1481. (Pubitemid 39006975)
12. Greene, E.L., Velarde, V., and Jaffa, A.A. (2000). Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-Fos induction in vascular cells. Hypertension 35, 942-947. (Pubitemid 30303955)
13. Gu, K., Cowie, C.C., and Harris, M.I. (1998). Mortality in adults with and without diabetes in a national cohort of the U.S. population 1971-1993. Diabetes Care 21, 1138-1145. (Pubitemid 28368522)
14. Hocquette, J.F., Graulet, B., and Olivecrona, T. (1998). Lipopro-tein lipase activity and mRNA levels in bovine tissues. Comp. Biochem. Physiol. 121, 201-212. (Pubitemid 29017655)
15. Iwasaki, T., Takahashi, S., Takahashi, M., Zenimaru, Y., Kujir-aoka, T., Ishihara, M., Nagano, M., Suzuki, J., Miyamori, I., Naiki, H., Sakai, J., Fujino, T., Miller, N.E., Yamamoto, T.T., and Hattori, H. (2005). Deficiency of the very low-density li-poprotein (VLDL) receptors in streptozotocin-induced diabetic rats: Insulin dependency of the VLDL receptor. Endocrinology 146, 3286-3294. (Pubitemid 41058099)
16. Jaffa, A.A., Durazo-Arvizu, R., Zheng, D., Lackland, D.T., Sri-kanth, S., Garvey, W.T., and Schmaier, A.H. (2003). Plasma prekallikrein: A risk marker for hypertension and nephropa-thy in type 1 diabetes. Diabetes 52, 1215-1221. (Pubitemid 36523359)
17. Jokinen, E.V., Landschulz, K.T., Wyne, K.L., Ho, Y.K., Frykman, P.K., and Hobbs, H.H. (1994). Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J. Biol. Chem. 269, 26411-26418. (Pubitemid 24328463)
18. Kim, D.H., Magoori, K., Inoue, T.R., Mao, C.C., Kim, H.J., Suzuki, H., Fujita, T., Endo, Y., Saeki, S., and Yamamoto, T.T. (1997). Exon/intron organization, chromosome localization, alternative splicing, and transcription units of the human apolipoprotein E receptor 2 gene. J. Biol. Chem. 272, 8498-8504. (Pubitemid 27147813)
19. Kobayashi, K., Oka, K., Forte, T., Ishida, B., Teng, B., Ishimura-Oka, K., Nakamuta, M., and Chan, L. (1996). Reversal of hy-percholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J. Biol. Chem. 271, 6852-6860. (Pubitemid 26104786)
20. Kounnas, M.Z., Chappell, D.A., Strickland, D.K., and Argraves, W.S. (1993). Glycoprotein 330, a member of the low density lipoprotein receptor family, binds lipoprotein lipase in vitro. J. Biol. Chem. 268, 14176-14181. (Pubitemid 23195539)
21. Liang, K., and Vaziri, N.D. (1997). Acquired VLDL receptor deficiency in experimental nephrosis. Kidney Int. 51, 1761-1765. (Pubitemid 27252744)
22. Liu, F., Kim, J., Li, Y., Liu, X., Li, J., and Chen, X. (2001). An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J. Nutr. 131, 2242-2247. (Pubitemid 32851863)
23. MacDougall, E.D., Kramer, F., Polinsky, P., Barnhart, S., Askari, B., Johansson, F., Varon, R., Rosenfeld, M.E., Oka, K., Chan, L., Schwartz, S.M., and Bornfeldt, K.E. (2006). Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice. Am. J. Pathol. 168, 2064-2073. (Pubitemid 43825324)
24. Monahan, P.E., and Samulski, R.J. (2000). AAV vectors: Is clinical success on the horizon? Gene Ther. 7, 24-30. (Pubitemid 30077145)
25. Multhaupt, H.A., Gafvels, M.E., Kariko, K., Jin, H., Arenas-Elliot, C., Goldman, B.I., Strauss, J.F., III, Angelin, B., Warhol, M.J., and McCrae, K.R. (1996). Expression of very low density lipoprotein receptor in the vascular wall: Analysis of human tissues by in situ hybridization and immunohistochemistry. Am. J. Pathol. 148, 1985-1997.
26. Nomura, S., Merched, A., Nour, E., Dieker, C., Oka, K., and Chan, L. (2004). Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia. Gene Ther. 11, 1540-1548. (Pubitemid 39359462)
27. Oka, K., Ishimura-Oka, K., Chu, M.J., Sullivan, M., Krushkal, J., Li, W.H., and Chan, L. (1994a). Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor. Eur. J. Biochem. 224, 975-982. (Pubitemid 24288861)
28. Oka, K., Tzung, K.W., Sullivan, M., Lindsay, E., Baldini, A., and Chan, L. (1994b). Human very-low-density lipoprotein receptor complementary DNA and deduced amino acid sequence and localization of its gene (VLDLR) to chromosome band 9p24 by fluorescence in situ hybridization. Genomics 20, 298-300. (Pubitemid 24108414)
29. Oka, K., Pastore, L., Kim, I.H., Merched, A., Nomura, S., Lee, H.J., Merched-Sauvage, M., Arden-Riley, C., Lee, B., Finegold, M., Beaudet, A., and Chan, L. (2001). Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation 103, 1274-1281. (Pubitemid 32221352)
30. Pollare, T. (1990). Insulin sensitivity and blood lipids during antihypertensive treatment with special reference to ACE inhibition. J. Diabet. Complications 4, 75-78. (Pubitemid 20271030)
31. Ricort, J.M., Tanti, J.F., Van Obberghen, E., and Le Marchand-Brustel, Y. (1995). Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes. Diabetologia 38, 1148-1156.
32. Sakai, J., Hoshino, A., Takahashi, S., Miura, Y., Ishii, H., Suzuki, H., Kawarabayasi, Y., and Yamamoto, T. (1994). Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J. Biol. Chem. 269, 2173-2182. (Pubitemid 24035430)
33. Salinelli, S., Lo, J.Y., Mims, M.P., Zsigmond, E., Smith, L.C., and Chan, L. (1996). Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor: Functional importance of a properly folded surface loop covering the catalytic center. J. Biol. Chem. 271, 21906-21913. (Pubitemid 26303813)
34. Sato, T., Liang, K., and Vaziri, N.D. (2002). Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glo-merulosclerosis. Kidney Int. 61, 157-162. (Pubitemid 34075142)
35. Srinivasan, S.R., Frontini, M.G., and Berenson, G.S. (2003). Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: The Bogalusa Heart Study. Metabolism 52, 443-450. (Pubitemid 36773266)
36. Tacken, P.J., Teusink, B., Jong, M.C., Harats, D., Havekes, L.M., van Dijk, K.W., and Hofker, M.H. (2000). LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice. J. Lipid Res. 41, 2055-2062. (Pubitemid 32039001)
37. Takahashi, S., Kawarabayasi, Y., Nakai, T., Sakai, J., and Ya-mamoto, T. (1992). Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. U.S.A. 89, 9252-9256.
38. Takahashi, S., Suzuki, J., Kohno, M., Oida, K., Tamai, T., Miyabo, S., Yamamoto, T., and Nakai, T. (1995). Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J. Biol. Chem. 270, 15747-15754.
39. Van Dijk, K.W., van Vlijmen, B.J., van der Zee, A., van't Hof, B., van der Boom, H., Kobayashi, K., Chan, L., Havekes, L.M., and Hofker, M.H. (1998). Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor. Arterioscler. Thromb. Vasc. Biol. 18, 7-12. (Pubitemid 28047592)
40. Vaziri, N.D., and Liang, K. (1997). Down-regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int. 51, 913-919. (Pubitemid 27157982)
41. Webb, J.C., Patel, D.D., Jones, M.D., Knight, B.L., and Soutar, A.K. (1994). Characterization and tissue-specific expression of the human "very low density lipoprotein (VLDL) receptor" mRNA. Hum. Mol. Genet. 3, 531-537.
42. 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP. J. Biol. Chem. 269, 8653-8658.
43. Yagyu, H., Lutz, E.P., Kako, Y., Marks, S., Hu, Y., Choi, S.Y., Bensadoun, A., and Goldberg, I.J. (2002). Very low density lipoprotein (VLDL) receptor-deficient mice have reduced li-poprotein lipase activity: Possible causes of hypertriglycer-idemia and reduced body mass with VLDL receptor deficiency. J. Biol. Chem. 277, 10037-10043. (Pubitemid 34968113)
44. 0-monophosphate-activated protein kinase signaling pathways. Endocrinology 148, 2016-2026. (Pubitemid 46997049)